In breast and pancreatic cancer cells, FAK is assumed to act up-stream of the Wnt/β-catenin pathway [40], while in other systems, FAK acts downstream of Wnt promoting AKT/mTOR activation in vivo and leading to increased intestinal cell proliferation and tumorigenesis [54]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.